PHILADELPHIA— Revelations that some members of Congress, including members of key health care committees, hold substantial personal investments in the health care industry have raised concerns about lawmakers’ financial conflicts of interest and their potential impact on health care legislation and oversight. Now, a new study shows that over a third of all members of Congress held health care-related assets with a median total value per member of over $43,000 between 2004 and 2014.
Using personal financial disclosures for members of the House and Senate over that 10-year period, researchers found that while members of health care-focused committees and subcommittees in the House and Senate held health care-related assets at the same rate as other members of Congress, multiple members of these committees and subcommittees held hundreds of thousands of dollars of health care-related assets during their committee service.
“All members of Congress have the opportunity to vote on health care policy that impacts the lives of all Americans,” said lead author Matthew McCoy, PhD, an assistant professor of Medical Ethics and Health Policy. “We should hold members of Congress to a higher standard and expect that they divest from assets in industries directly affected by their committee work to preserve the integrity of their policy-making.”
At the start of the sample period in 2004 across both chambers, a higher percentage of Republicans than Democrats held health care-related assets. However, party differences diminished over time. In 2014, there was little difference in health-care related asset holding by party in the House.
“Given that making policy changes in the health care industry could impact any investments a member has, their voting could be biased toward their own financial gain,” added senior author Genevieve Kanter, PhD, an assistant professor of General Internal Medicine and Medical Ethics and Health Policy. “In order to understand the significance of these financial holdings and the importance of disclosures, there needs to be more research into how these financial assets actually influence policymaking.”
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.